BridgeBio Pharma Inc Strategic Asset Allocation Index
BridgeBio Pharma Inc strategic asset allocation index. BridgeBio Pharma Inc (BBIO) has a Strategic Asset Allocation Index of 18.8% as of December 2020. Strategic assets (PP&E of $20.32 Million plus long-term investments of $0.00) total $20.32 Million, measured against net assets of $107.89 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See BBIO equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of BridgeBio Pharma Inc (2019–2020)
Strategic asset allocation index of BridgeBio Pharma Inc from 2019 to 2020. This chart shows how BridgeBio Pharma Inc's Strategic Asset Allocation Index has evolved across 2 annual periods from 2019 to 2020. As of December 2020, the index stands at 18.8%, representing strategic assets of $20.32 Million against net assets of $107.89 Million USD. Check tangible net worth ratio of BridgeBio Pharma Inc to evaluate the tangible quality of the company's equity base.
BridgeBio Pharma Inc Strategic Asset Allocation Index by Year (2019–2020)
BridgeBio Pharma Inc strategic asset allocation index by year from 2019 to 2020. The table below presents the year-by-year Strategic Asset Allocation Index for BridgeBio Pharma Inc from 2019 to 2020, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see BridgeBio Pharma Inc (BBIO) market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2020 | 18.8% | $20.32 Million | $20.32 Million | $0.00 | $107.89 Million | ▲ +11.1 pp |
| 2019 | 7.7% | $36.77 Million | $5.62 Million | $31.14 Million | $475.98 Million | — |